• Iovance Biotherapeutics granted inducement stock options covering 240,135 shares to 20 new non-executive employees on Aug. 20, 2026.
• Options carry an exercise price of $8.99, matching the stock’s closing price on the grant date.
• Vesting runs over three years, with one-third vesting on the first anniversary of the start date.
• Remaining shares vest in eight quarterly installments over the next two years, contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608211715PRIMZONEFULLFEED9814407) on August 21, 2026, and is solely responsible for the information contained therein.